Equifax Inc. (EFXB31)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 969.34 |
|---|---|
| 52-week range | 960.60 – 969.34 |
| Return, 1 month / 3 months | +0.0% / +0.3% |
| Return, 1 year / 3 years | +0.9% / – |
| Trend | Uptrend |
| RSI (14) | 100 |
| Volatility (1 year) | 0.5% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Equifax Inc. is a credit reporting and information services company based in the United States. It gathers and maintains data on consumers and businesses, then provides credit reports, credit scores and identity verification services. Its customers include banks, lenders, employers, insurers and government agencies that use the information to assess creditworthiness and manage risk. Equifax also offers analytics and workforce verification tools to help organisations make decisions about lending, hiring and fraud prevention.
Equifax Inc. trades under the code EFXB31 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Equifax Inc. (EFXB31) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 969.34 on 15 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 601 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.9% and over the last three months it rose 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.4% | ||
| From 52-week high | 0.0% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.3% | ||
| 6-month return | 0.5% | ||
| 12-month return, skipping the last month | 0.9% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 0.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 100.0% | ||
| Income | 17 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.3% |
| 6 months | +0.5% |
| 1 year | +0.9% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 968.24 / 965.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.02 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Aug 2026 | USD 2.8960 |
| 22 May 2026 | USD 1.9709 |
| 9 Mar 2026 | USD 2.0309 |
| 24 Nov 2025 | USD 1.8724 |
| 2 Sep 2025 | USD 1.9081 |
| 23 May 2025 | USD 1.9509 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.